Insider Holders & Insider Ownership - Phio Pharmaceuticals Corp. (PHIO)

List of insiders holdings for Phio Pharmaceuticals Corp.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 Galena Biopharma Inc.
10% Owner
2013-05-02 18:57:25 32,393,095
0
32,393,095 Form 4
2 Advanced RNA Technologies LLC
No longer 10% owner
2015-02-25 15:56:55 1,221,723
0
1,221,723 Form 13G
3 Eliseev Alexey
Chief Business Officer
2017-09-07 20:17:10 950,312
0
950,312 Form 4
4 Barrett John A
Chief Development Officer
2019-04-24 20:25:56 222,991
0
222,991 Form 4
5 Dispersyn Gerrit
President & CEO
2022-03-03 19:12:51 212,327
0
212,327 Form 4
6 Opko Health Inc.
10% Owner
2019-05-09 17:17:02 66,857
0
66,857 Form 13D
7 Dorman H. Paul
Director
2022-02-16 20:05:05 20,370
0
20,370 Form 4
8 Brownlie Keith L
Director
2019-02-15 21:06:01 20,000
0
20,000 Form 4
9 Bitterman Robert J
Chairman, Pres & CEO
2024-09-13 14:59:23 17,832
0
17,832 Form 4
10 Infarinato Robert M.
VP, CFO
2024-09-13 15:00:20 11,000
0
11,000 Form 4
11 Kontulis Caitlin
Secretary & VP Finance & Admin
2024-03-05 19:00:05 10,643
0
10,643 Form 4
12 Ferrara Robert L
Director
2024-09-12 16:11:23 10,000
0
10,000 Form 4
13 BRADFORD PATRICIA A
Director
2024-09-12 16:10:54 8,000
0
8,000 Form 4
14 Pavco Pamela
Chief Development Officer
2017-02-03 17:17:58 7,000
0
7,000 Form 4
15 CAUWENBERGH GEERT
Director
2023-02-22 19:15:10 4,235
0
4,235 Form 4
16 Lockshin Curtis
Director
2024-09-12 16:11:58 2,000
0
2,000 Form 4
17 Freeman Jonathan E
Director
2024-09-13 14:59:52 1000
0
1000 Form 4
18 Deming David H
Director
2025-03-04 16:58:30 0
0
0 Form 3